Skip to content
Screener

Labcorp Holdings LH Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Azenta logo
AzentaAZTA
$9M
Charles River Laboratories logo
Charles River LaboratoriesCRL
$587.56M+98.2%
Myriad Genetics logo
Myriad GeneticsMYGN
Quest Diagnostics logo
Quest DiagnosticsDGX
NeoGenomics logo
NeoGenomicsNEO
Exagen Inc. logo
Exagen Inc.XGN

Other financials

Income statement

See full
Revenue$3.7B+5.8%
Gross profit$1.1B+6.3%
Operating income$451.6M+14.5%
Net income$298.7M+25.6%
EPS (diluted)$3.64+28.2%

Balance sheet

See full
Cash & equivalents$141.8M-78.1%
Total debt$6.8B+11.8%
Total equity$8.6B+1.6%
Total assets$18.5B+2.6%

Cash flow

See full
Operating cash flow$445.5M-28.2%
CapEx$121.0M-4.0%
Free cash flow$313.9M-42.2%

Valuation

See full
Market cap$25.88B+17.2%
Enterprise value$32.5B+18.2%
P/E25.8×-3.1×
P/S1.8×+0.2×

Profitability

See full
Gross margin28.9%+0.7pp
Operating margin10.4%+1.6pp
Net margin7%+1.3pp
FCF margin8.1%-1.3pp

Returns & leverage

See full
Return on equity11.7%+2.5pp
Debt / equity0.8×+0.1×
Current ratio1.8×+0.3×

Where this comes from

Reported directly by Labcorp Holdings in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The source filing: Labcorp Holdings’s 10-Q, filed May 4, 2026.

Filed
May 4, 2026, 2:10 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0000920148-26-000139
Line itemMarch 31, 2026December 31, 2025
Goodwill, net6,955.26,789.5
Intangible assets, net3,636.13,596.0
Joint venture partnerships and equity method investments146.6153.9
Other assets, net724.9751.3
Total assets$19,087.1$18,392.7
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable$695.7$840.8

ITEM 1. FINANCIAL STATEMENTS

FAQ

What is Labcorp Holdings's deferred tax assets and other non-current assets?
Labcorp Holdings (LH) reported deferred tax assets and other non-current assets of $724.9M in Q1 2026.
How has Labcorp Holdings's deferred tax assets and other non-current assets changed year-over-year?
Labcorp Holdings's deferred tax assets and other non-current assets increased by 12.0% year-over-year, from $647M to $724.9M.
What is the long-term trend for Labcorp Holdings's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), Labcorp Holdings's deferred tax assets and other non-current assets has grown at a 12.9% compound annual growth rate (CAGR), from $410M to $751.3M.

Ask your AI about Labcorp Holdings's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude